Features of the SIVmac transmembrane glycoprotein cytoplasmic domain that are important for ENV functions

AIDS Research and Human Retroviruses

Volumn 14, Issue 5, 1998, Pages 373-383

  Shacklett, Barbara L ^a,b   Denesvre, Caroline ^a   Boson, Bertrand ^a   Sonigo, Pierre ^a  

^a INSTITUT COCHIN   (France)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS MAC TRANSMEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS INFECTIVITY;

EID: 0032549620     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.373     Document Type: Article

References (44)

1. Hunter E and Swanstrom R: Retrovirus envelope glycoproteins. Curr Topics Microbiol Immunol 1990;157:187-253.
2. Gallaher W, Ball J, Garry R, Griffin M, and Montelaro R: A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 1989;5:431-440.
3. Pancino GF, Ellerbrok H, Sitbon M, and Sonigo P: Conserved framework of envelope glycoproteins among lentiviruses. In: Simian Immunodeficiency Viruses (Letvin NL and Desrosiers RC, eds.). Springer-Verlag, Berlin, 1994, pp. 77-105.
4. Miller MA, Cloyd MW, Liebmann J, Rinaldo CR, Islam KR, Wang SZS, Mietzner TA, and Montelaro RC: Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 1993;196:89-100.
5. Srinivas S, Srinivas R, Anantharamaiah G, Segrest J, and Compans R: Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoproteins. J Biol Chem 1992;267: 7121-7127.
6. Tencza SB, Miller MA, Islam K, Mietzner TA, and Montelaro RC: Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. J Virol 1995;69:5199-5202.
7. Venable RM, Pastor RW, Brooks BR, and Carson FW: Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 protein. AIDS Res Hum Retroviruses 1989;5:7-22.
8. Haffar OK, Dowbenko DJ, and Berman PW: The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes. Virology 1991;180:439-441.
9. Johnston PB, Dubay JW, and Hunter E: Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J Virol 1993;67:3077-3086.
10. Jowett JBM and Jones IM: Glycosylation of the external domain of SIV gp41 is influenced by the cytoplasmic tail. AIDS Res Hum Retroviruses 1993;9:197-198. [Letter]
11. LaBranche C, Sauter M, Haggarty B, Vance P, Romano J, Hart T, Bugelski P, Marsh M, and Hoxie J: A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol 1995;69:5217-5227.
12. Ritter GDJ, Mulligan MJ, Lydy SJ, and Compans RC: Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 1993;197: 255-264.
13. Sauter M, Pelchen-Matthews A, Bron R, Marsh M, LaBranche C, Vance P, Romano J, Haggarty B, Hart T, Lee W, and Hoxie J: An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol 1996;132: 795-811.
14. Spies CP and Compans RW: Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 1994;203:8-19.
15. Zingler K and Littman DR: Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J Virol 1993;67:2824-2831.
16. Freed E and Martin M: Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 1996;70:341-351.
17. Chakrabarti L, Emerman M, Tiollais P, and Sonigo P: The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J Virol 1989;63:4395-4403.
18. Lodge R, Göttlinger H, Gabuzda D, Cohen EA, and Lemay G: The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 1994;68:4857-4861.
19. Cosson P: Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 1996;15:5783-5788.
20. Spector D, Wade E, Wright D, Koval V, Clark C, Jaquish D, and Spector S: Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990;64:2298-2308.
21. Wilk T, Pfeiffer T, and Bosch V: Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 1992;189:167-177.
22. Dubay JW, Roberts SJ, Hahn BH, and Hunter E: Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks infectivity. J Virol 1992;66: 6616-6625.
23. Gabuzda DH, Lever A, Terwilliger E, and Sodroski J: Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1992;66:3306-3315.
24. Yu X, Yuan X, McLane M, Lee T-H, and Essex M: Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol 1993;67:213-221.
25. Kodama T, Wooley DP, Naidu YM, Kestler HW, Daniel MD, Li Y, and Desrosiers RC: Significance of premature stop codons in env of simian immunodeficiency virus. J Virol 1989;63: 4709-4714.
26. Hirsch VM, Edmonson P, Murphey-Corb M, Arbeille B, Johnson PR, and Mullins JI: SIV adaptation to human cells. Nature (London) 1989;341:573-574.
27. Franchini G, Kanki PK, Bosch ML, Fargnoli K, and Wong-Staal F: The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals. AIDS Res Hum Retroviruses 1988;4:251-258.
28. Kornfeld H, Riedel N, Viglianti G, Hirsch V, and Mullins J: Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (London) 1987;326:610-613.
29. Regier DA and Desrosiers RC: The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990;6:1221-1231.
30. Maniatis T, Frisch E, and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1982.
31. Potts B: "Mini" reverse transcriptase assay. In: Techniques in HIV Research (Aldovini A and Walker B, eds.). Stockton Press, New York, 1990, pp. 103-106.
32. Chackerian B, Haigwood N, and Overbaugh J: Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 1995;213:386-394.
33. Beisel CE, Edwards JF, Dunn LL, and Rice NR: Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol 1993;67:832-842.
34. Hirsch V, Riedel N, and Mullins J: The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell 1987;49:307-319.
35. Rein A, Mirro J, Haynes JG, Ernst SM, and Nagashima K: Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol 1994;68: 1773-1781.
36. Spies CP, Ritter GDJ, Mulligan MJ, and Compans RW: Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 1994;68:585-591.
37. Mulligan M, Yamshchikov G, Ritter G, Gao F, Jin M, Nail C, Spies C, Hahn B, and Compans R: Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J Virol 1992;66:3971-3975.
38. Denesvre C, Carrington C, Corbin A, Takeuchi Y, Cosset F-L, Schulz T, Sitbon M, and Sonigo P: TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol 1996;70:4380-4386.
39. Hill CP, Worthylake D, Bancroft DP, Christensen AM, and Sundquist WI: Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly. Proc Natl Acad Sci USA 1996;93: 3099-3104.
40. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, and Stuart DI: Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (London) 1995;378:743-747.
41. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier J-L., and Trono D: The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 1997;6:67-77.
42. Hunter E: Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol 1994;5:71-83.
43. Zhang H, Dornadula G, Alur P, Laughlin M, and Pomerantz R: Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: A molecular mechanism underlying natural endogenous reverse transcription. Proc Natl Acad Sci USA 1996;93:12519-12524.
44. Luciw P, Shaw K, Shacklett B, and Marthas M: In preparation (1998).